PROMENTIS PHARMACEUTICALS
Promentis Pharmaceuticals discovers, develops, and markets new drugs for the treatment of important human diseases, focusing initially on developing a new antipsychotic drug to treat schizophrenia. Promentis Pharmaceuticals was founded in 2006 and is based in Milwaukee, Wisconsin.
PROMENTIS PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2006-01-01
Address:
Milwaukee, Wisconsin, United States
Country:
United States
Website Url:
http://www.promentispharma.com
Total Employee:
11+
Status:
Active
Contact:
(414)238-2992
Email Addresses:
[email protected]
Total Funding:
63.85 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager WordPress Google Universal Analytics Apache
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
PaxVax
PaxVax is a start-up developing candidate oral vaccines for key infectious diseases.
PhaseBio Pharmaceuticals
PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Current Advisors List
Current Employees Featured
Founder
Investors List
F-Prime Capital
F-Prime Capital investment in Series C - Promentis Pharmaceuticals
Aisling Capital
Aisling Capital investment in Series C - Promentis Pharmaceuticals
Black Pearl Capital Partners
Black Pearl Capital Partners investment in Series C - Promentis Pharmaceuticals
Golden Triangle Angel Network
Golden Triangle Angel Network investment in Series C - Promentis Pharmaceuticals
OrbiMed
OrbiMed investment in Series C - Promentis Pharmaceuticals
F-Prime Capital
F-Prime Capital investment in Venture Round - Promentis Pharmaceuticals
Golden Angels Investors
Golden Angels Investors investment in Venture Round - Promentis Pharmaceuticals
Golden Angels Investors
Golden Angels Investors investment in Series B - Promentis Pharmaceuticals
Black Horse Investments
Black Horse Investments investment in Series B - Promentis Pharmaceuticals
Golden Angels Investors
Golden Angels Investors investment in Debt Financing - Promentis Pharmaceuticals
Official Site Inspections
http://www.promentispharma.com
- Host name: cvps1757071158871.hostwindsdns.com
- IP address: 23.254.201.107
- Location: Seattle United States
- Latitude: 47.4902
- Longitude: -122.3004
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98168
